Company overview
EUROIMMUN, part of Revvity, is an international provider of medical laboratory diagnostic products and automation solutions for autoimmune, infectious disease, allergy, endocrinology, and neurological testing. The company offers indirect immunofluorescence assays (IFA), ELISAs, immunoblots, chemiluminescence immunoassays (ChLIA), and PCR-based systems spanning over 1,000 diagnostic parameters. With more than 3,400 employees across 17 countries, EUROIMMUN serves laboratories in over 140 countries and provides state-of-the-art instruments and software for efficient automation of routine diagnostics.
Euroimmun is listed in the NovaPharmaNews Supplier Hub as a Diagnostics & Testing, Lab Equipment & Instruments partner serving United States & Americas. Core focus areas include medical laboratory diagnostics, chemiluminescence immunoassays, autoimmune disease testing, diagnostic automation platforms, infectious disease diagnostics.
Industry categories: Diagnostics & Testing, Lab Equipment & Instruments. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://www.euroimmun.com
- Categories
- Diagnostics & Testing, Lab Equipment & Instruments
- Markets served
- United States & Americas
- Keywords
- medical laboratory diagnostics, chemiluminescence immunoassays, autoimmune disease testing, diagnostic automation platforms, infectious disease diagnostics
Products & technologies
Therapeutic areas
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What diagnostic specialties does EUROIMMUN cover?
- EUROIMMUN provides test systems for autoimmune diseases, infectious diseases, allergies, endocrinology, bone metabolism, neurodegeneration, therapeutic drug monitoring, and Alzheimer's disease diagnostics. The company's portfolio encompasses over 1,000 diagnostic parameters across these specialties.
- What automation platforms does EUROIMMUN offer?
- EUROIMMUN offers fully automated platforms including the IDS i20 analytical random access platform for chemiluminescence immunoassays (capable of processing up to 140 tests per hour), the EUROLabWorkstation IFA for automated immunofluorescence processing, and the EUROBlotOne for automated immunoblot analysis. These platforms enable consolidation of multiple specialty tests on single instruments with high throughput and standardized processing.
- What is EUROIMMUN's regulatory status and global reach?
- EUROIMMUN products are CE marked and FDA listed devices. The company operates in 17 countries with more than 3,400 employees and serves laboratories in over 140 countries worldwide. EUROIMMUN US, headquartered in New Jersey, provides specialized support for US and Canadian markets.
- What assay technologies does EUROIMMUN specialize in?
- EUROIMMUN specializes in indirect immunofluorescence assays (IFA), ELISAs, immunoblots, chemiluminescence immunoassays (ChLIA), and PCR-based test systems. The company focuses on test systems for antibodies in patient serum, enabling highly sensitive and specific diagnosis across multiple disease categories.
- How long has EUROIMMUN been in the medical device industry?
- EUROIMMUN's IDS i-device series is built on more than 50 years of experience in medical device design and innovation, demonstrating extensive expertise in developing diagnostic instrumentation and solutions for clinical laboratories.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
